Menopausal Hot Flashes Market:
Introduction
According to the report, the
global menopausal
hot flashes market was valued at approximately US$ 9.5 Bn in 2018. It
is expected to expand at a CAGR of 6% during the forecast period from 2019 to
2027. Menopause is the time, which marks the end of a woman’s menstrual cycle.
This can happen majorly in the age period between 40s or 50s. The most common
menopausal symptoms, including vasomotor symptoms (hot flashes), insomnia,
vaginal atrophy, altered cognitive function, dementia, depression, and loss of
muscle mass, can affect up to 80% of women during menopause and may be severe
in up to 20% of these women. The use of hormone replacement therapy (HRT)
alleviates menopausal symptoms and lead to a major improvement in quality of
life for women with menopausal symptoms. Alternative therapies such as herbal
drugs are also effective in treating the vasomotor symptoms, urogenital atrophy
symptoms, and irregular menstrual bleeding that occur in the premenopausal
period. The market is dominated by North America region in 2018, which is
expected to dominate by the end of 2027.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2856
Growing Population of Elderly
Women Worldwide and Rise in Menopausal Vasomotor Symptoms Drive Menopausal Hot
Flashes Market
Menopausal symptoms occur mostly
after the age of 51 years. Rapidly increasing population of geriatric women
leads to rise in the number of women with menopausal symptoms. According to the
United Nations World Population Aging Report - 2017, women accounted for 54%
share of the global population aged 60 years or above and 61% of that aged 80
years or above in 2017. Increase in awareness about women’s health through
government initiatives have changed the scenario and people are focusing more
on women’s health, which is driving the global menopausal hot flashes market.
Moreover, development of advanced products with alternative mode of
administration and changes in lifestyle associated with early menopause are
some of the major factors responsible for the growth of global menopausal hot
flashes market.
Preference for Hormonal
Treatment Due to Better Efficacy of Hormone Replacement Therapy
Based on treatment type, the
global menopausal hot flashes market has been divided into hormonal treatment,
non-hormonal treatment, and alternative treatment. Hormonal treatment dominated
the global menopausal hot flashes market due to better efficacy of hormone
replacement therapy and approval of combination products. The hormonal
treatment segment is further sub-segmented into estrogen, progesterone, and
estrogen–progesterone combination.The non-hormonal treatment is growing with a
higher CAGR during the forecast period owing to lesser risk of developing breast
cancer. This segment is further classified into antidepressant, gabapentin,
pregabalin, and clonidine. The antidepressant sub-segment is further divided
into Paroxetine, Fluoxetine, Venlafaxine, Desvenlafaxine, and others. The
alternative segment is sub-divided into black cohosh, vitamin E, herbal
medicines, and others.
Request for Analysis of COVID-19 Impact on Menopausal Hot
Flashes Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=2856
Growing Adoption for Online
Purchases
Based on distribution channel,
the global menopausal hot flashes market has been classified into hospital
pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies
segment dominated the global menopausal hot flashes market due to better supply
chain management and rise in number of patient admissions to hospitals. The
online pharmacies segment is expected to grow at a comparatively higher CAGR
during the forecast period, owing to growing adoption for online purchase due
to better discount rates and convenience to patients.
North America to Dominate
Global Market
In terms of region, the global
menopausal hot flashes market has been divided into five major regions: North
America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
Europe dominated the global menopausal hot flashes market in 2018. North
America accounted for a major share of the global menopausal hot flashes market
in 2018 due to growing baby boomer population, high health care expenditure,
and large number of prescriptions of hormonal as well as non-hormonal treatment
products. For instance, in the U.S., around 40 million post-menopausal women
are present and this number is increasing at a rate of 4,000 per day, due to
the aging ‘baby boomer’ population. Asia Pacific is projected to grow with
higher CAGR during the forecast period. This growth can be ascribed to rise in
elderly population, large number of women with menopausal symptoms, growing
awareness among people, increasing medical tourism, and rising government
initiatives for women’s health in the region.
Buy Menopausal Hot Flashes Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=2856<ype=S
Competition Landscape
Pfizer Inc., Novartis AG, and
Novo Nordisk A/S are some of the leading players in the global menopausal hot
flashes market. The global menopausal hot flashes market is fragmented in terms
of number of players with entry of several generic players. Key players in the
global market include Pfizer Inc., Novartis AG, Novo Nordisk A/S, Allergan plc,
Teva Pharmaceutical Industries Ltd., Mylan N.V., Hisamitsu Pharmaceutical Co.,
Inc., Merck & Co., Inc., GlaxoSmithKline plc, and TherapeuticsMD, Inc. New
product approvals & launch of generic versions, strategic collaborations
& partnerships, and extensive research & development activities are
some of the key strategies adopted by major players in the menopausal hot
flashes market.
More Trending Reports by
Transparency Market Research –
Oncology Biosimilars Market: https://www.biospace.com/article/oncology-biosimilars-market-efforts-of-key-players-to-widen-their-offerings-and-patent-expiration-to-boost-growth/
Read our Case study at https://www.transparencymarketresearch.com/casestudies/innovative-medical-device-manufacturing-start-up
About Us
Transparency Market Research is a
global market intelligence company providing global business information
reports and services. Our exclusive blend of quantitative forecasting and
trends analysis provides forward-looking insight for several decision makers.
Our experienced team of analysts, researchers, and consultants use proprietary
data sources and various tools and techniques to gather and analyze
information.
Our data repository is
continuously updated and revised by a team of research experts so that it
always reflects latest trends and information. With a broad research and
analysis capability, Transparency Market Research employs rigorous primary and
secondary research techniques in developing distinctive data sets and research
material for business reports.
Contact
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free:
866-552-3453
